PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.75%
Negative net income growth while MCHP stands at 6.24%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
6.67%
Some D&A expansion while MCHP is negative at -3.10%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-90.38%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-28.83%
Negative yoy SBC while MCHP is 6.54%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
98.82%
Less working capital growth vs. MCHP's 426.85%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
74.68%
AR growth while MCHP is negative at -454.24%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
59.41%
Some inventory rise while MCHP is negative at -7.51%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-63.51%
Negative yoy AP while MCHP is 1102.47%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
359.38%
Lower 'other working capital' growth vs. MCHP's 2945.21%. David Dodd would see fewer unexpected short-term demands on cash.
61.63%
Well above MCHP's 45.24%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
38.46%
Operating cash flow growth at 50-75% of MCHP's 61.11%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-3.39%
Both yoy lines negative, with MCHP at -28.11%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
23.89%
Purchases growth of 23.89% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-5.87%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-111.90%
Both yoy lines negative, with MCHP at -11.22%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
28.97%
We have mild expansions while MCHP is negative at -25.46%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
We repay more while MCHP is negative at -10.72%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
4.62%
We slightly raise equity while MCHP is negative at -32.38%. John Neff sees competitor possibly preserving share count or buying back shares.
41.77%
Repurchase growth above 1.5x MCHP's 7.16%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.